Asarina Pharma ApS: Financial statements 2020
CVR: 38495712
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Asarina Pharma ApS (CVR 38495712) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,890,785 and a net result of DKK -51,528,246 compared with DKK -52,387,015 the year before. Equity in the 2020 report amounted to DKK 44,077,253. The solvency ratio was 71.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,890,785
- Profit/Loss
- DKK -51,528,246
- Equity
- DKK 44,077,253
- Total Assets
- DKK 61,607,140
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -1.9 mio. | -51.5 mio. | 44.1 mio. | 2 |
| 2019 | - | -1.4 mio. | -52.4 mio. | 51.1 mio. | 3 |
| 2018 | - | -891.9 mio. | -31.3 mia. | 12.1 mia. | - |
Official annual report
How creditworthy is Asarina Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Asarina Pharma ApS has published its annual report for 2019. Gross profit came to DKK -1,446,125, and the net result was DKK -52,387,015.
About Asarina Pharma ApS
Asarina Pharma ApS was a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Asarina Danmark ApS. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK -365,453 and a net result of DKK -1,333,232 compared with DKK -42,903,193 the year before. Equity in the 2024 report amounted to DKK -107,343.